Diagnamed Holdings Corp. (CSE:DMED)

Diagnamed Holdings Cash Flow Statement

Financials in millions CAD. Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Net Income	-0.5	-1.28	-1.13	-1.95
Stock-Based Compensation	-	0.01	0.14	-
Other Operating Activities	-0.22	0.05	-	1.26
Change in Accounts Receivable	0.02	-0.01	-0.01	-0.03
Change in Accounts Payable	0.26	0.16	0.22	0.15
Change in Other Net Operating Assets	-0.01	-	-	-
Operating Cash Flow	-0.44	-1.07	-0.79	-0.57
Cash Acquisitions	-	-	-	0.03
Investing Cash Flow	-	-	-	0.03
Issuance of Common Stock	-	0.1	-	2.97
Other Financing Activities	-	-	-	-0.08
Financing Cash Flow	-	0.1	-	2.89
Net Cash Flow	-0.44	-0.96	-0.79	2.36
Free Cash Flow	-0.44	-1.07	-0.79	-0.57
Free Cash Flow Per Share	-0.01	-0.01	-0.01	-0.01
Levered Free Cash Flow	-0.36	-0.68	-0.36	-
Unlevered Free Cash Flow	-0.36	-0.68	-0.36	-
Change in Net Working Capital	-0.06	-0.05	-0.21	-

Source: S&P Capital IQ. Standard template. Financial Sources.